{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:38:50Z","timestamp":1793039930969,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA108961"],"award-info":[{"award-number":["P50 CA108961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA136393"],"award-info":[{"award-number":["P50 CA136393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA154348"],"award-info":[{"award-number":["R01 CA154348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA200507"],"award-info":[{"award-number":["R01 CA200507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007093","name":"Richard M. Schulze Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/jnci\/djy033","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T20:10:02Z","timestamp":1520367002000},"page":"1123-1132","source":"Crossref","is-referenced-by-count":114,"title":["Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy"],"prefix":"10.1093","volume":"110","author":[{"given":"Cheyne","family":"Kurokawa","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ianko D","family":"Iankov","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Keith","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Aderca","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A","family":"Leontovich","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L","family":"Oberg","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Giannini","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M","family":"Greiner","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A","family":"Becker","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Aubrey","family":"Thompson","sequence":"additional","affiliation":[{"name":"Cancer Biology, Mayo Clinic Florida, Jacksonville, FL, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Haluska","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Jentoft","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F","family":"Parney","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S John","family":"Weroha","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Jen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"},{"name":"Genome Analysis Core, Medical Genome Facility, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann N","family":"Sarkaria","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Galanis","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN"},{"name":"Division of Medical Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"issue":"7","key":"key\n\t\t\t\t20181014195311135_djy033-B1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of disseminated cancer after systemic oncolytic virotherapy","volume":"89","author":"Russell","year":"2014","journal-title":"Mayo Clinic Proc"},{"issue":"25","key":"key\n\t\t\t\t20181014195311135_djy033-B2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20181014195311135_djy033-B3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Galanis","year":"2015","journal-title":"Cancer Res"},{"issue":"7378","key":"key\n\t\t\t\t20181014195311135_djy033-B4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Muhlebach","year":"2011","journal-title":"Nature."},{"issue":"2","key":"key\n\t\t\t\t20181014195311135_djy033-B5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human Cd46 molecule is a receptor for measles-virus (Edmonston strain)","volume":"75","author":"Dorig","year":"1993","journal-title":"Cell."},{"issue":"6798","key":"key\n\t\t\t\t20181014195311135_djy033-B6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"issue":"8","key":"key\n\t\t\t\t20181014195311135_djy033-B7","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.ppat.1002240","article-title":"Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus","volume":"7","author":"Noyce","year":"2011","journal-title":"PLoS Pathog."},{"issue":"4","key":"key\n\t\t\t\t20181014195311135_djy033-B8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14712598.2013.749851","article-title":"Oncolytic measles virus strains as novel anticancer agents","volume":"13","author":"Msaouel","year":"2013","journal-title":"Exp Opin Biol Ther."},{"issue":"3","key":"key\n\t\t\t\t20181014195311135_djy033-B9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-09-2762","article-title":"Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer","volume":"70","author":"Galanis","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"key\n\t\t\t\t20181014195311135_djy033-B10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Galanis","year":"2015","journal-title":"Cancer Res."},{"issue":"13","key":"key\n\t\t\t\t20181014195311135_djy033-B11","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J Clin Oncol."},{"issue":"4","key":"key\n\t\t\t\t20181014195311135_djy033-B12","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"26","key":"key\n\t\t\t\t20181014195311135_djy033-B13","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1200\/JCO.2006.05.6861","article-title":"Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer","volume":"24","author":"Hess","year":"2006","journal-title":"J Clin Oncol."},{"issue":"7","key":"key\n\t\t\t\t20181014195311135_djy033-B14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2006.07.4187","article-title":"Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan","volume":"25","author":"Del Rio","year":"2007","journal-title":"J Clin Oncol."},{"issue":"27","key":"key\n\t\t\t\t20181014195311135_djy033-B15","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t20181014195311135_djy033-B16"},{"issue":"1","key":"key\n\t\t\t\t20181014195311135_djy033-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2331554","article-title":"The probable error of a mean","volume":"6","author":"Gosset","year":"1908","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t20181014195311135_djy033-B18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"key\n\t\t\t\t20181014195311135_djy033-B19","doi-asserted-by":"crossref","first-page":"W317","DOI":"10.1093\/nar\/gkp416","article-title":"GeneCodis: Interpreting gene lists through enrichment analysis and integration of diverse biological information","volume":"37","author":"Nogales-Cadenas","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20181014195311135_djy033-B20","doi-asserted-by":"crossref","first-page":"W478","DOI":"10.1093\/nar\/gks402","article-title":"GeneCodis3: A non-redundant and modular enrichment analysis tool for functional genomics","volume":"40","author":"Tabas-Madrid","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"key\n\t\t\t\t20181014195311135_djy033-B21","doi-asserted-by":"crossref","first-page":"RESEARCH0036","DOI":"10.1186\/gb-2002-3-7-research0036","article-title":"A prediction-based resampling method for estimating the number of clusters in a dataset","volume":"3","author":"Dudoit","year":"2002","journal-title":"Genome Biol."},{"key":"key\n\t\t\t\t20181014195311135_djy033-B22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1098\/rspl.1895.0041","article-title":"Notes on regression and inheritance in the case of two parents","volume":"58","author":"Pearson","year":"1895","journal-title":"Proc R Soc Lond."},{"issue":"6","key":"key\n\t\t\t\t20181014195311135_djy033-B23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1145\/362248.362263","article-title":"A computer generated aid for cluster analysis","volume":"16","author":"Ling","year":"1973","journal-title":"Commun ACM."},{"issue":"7 Pt 1","key":"key\n\t\t\t\t20181014195311135_djy033-B24","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/1078-0432.CCR-05-2510","article-title":"Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response","volume":"12","author":"Sarkaria","year":"2006","journal-title":"Clin Cancer Res."},{"issue":"5","key":"key\n\t\t\t\t20181014195311135_djy033-B25","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv369","article-title":"Delineation of MGMT hypermethylation as a biomarker for veliparib-mediated temozolomide-sensitizing therapy of glioblastoma","volume":"108","author":"Gupta","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"key\n\t\t\t\t20181014195311135_djy033-B26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1215\/S1152851704000821","article-title":"Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme","volume":"7","author":"Giannini","year":"2005","journal-title":"Neuro-oncology."},{"issue":"11","key":"key\n\t\t\t\t20181014195311135_djy033-B27","doi-asserted-by":"crossref","first-page":"9568","DOI":"10.1128\/JVI.73.11.9568-9575.1999","article-title":"Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus","volume":"73","author":"Duprex","year":"1999","journal-title":"J Virol"},{"issue":"7485","key":"key\n\t\t\t\t20181014195311135_djy033-B28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature12862","article-title":"Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity","volume":"505","author":"Schoggins","year":"2014","journal-title":"Nature."},{"key":"key\n\t\t\t\t20181014195311135_djy033-B29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: A complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol."},{"issue":"6455","key":"key\n\t\t\t\t20181014195311135_djy033-B30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/366583a0","article-title":"Interferon-induced nuclear signalling by Jak protein tyrosine kinases","volume":"366","author":"Silvennoinen","year":"1993","journal-title":"Nature."},{"issue":"1\u20132","key":"key\n\t\t\t\t20181014195311135_djy033-B31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2013.06.019","article-title":"The measles virus phosphoprotein interacts with the linker domain of STAT1","volume":"444","author":"Devaux","year":"2013","journal-title":"Virology."},{"issue":"21","key":"key\n\t\t\t\t20181014195311135_djy033-B32","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1128\/JVI.78.21.11632-11640.2004","article-title":"Measles virus phosphoprotein gene products: Conformational flexibility of the P\/V protein amino-terminal domain and C protein infectivity factor function","volume":"78","author":"Devaux","year":"2004","journal-title":"J Virol."},{"issue":"17","key":"key\n\t\t\t\t20181014195311135_djy033-B33","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1128\/JVI.00108-08","article-title":"Measles virus circumvents the host interferon response by different actions of the C and V proteins","volume":"82","author":"Nakatsu","year":"2008","journal-title":"J Virol."},{"issue":"7","key":"key\n\t\t\t\t20181014195311135_djy033-B34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat Med."},{"issue":"8","key":"key\n\t\t\t\t20181014195311135_djy033-B35","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.mt.6300193","article-title":"The RAS\/Raf1\/MEK\/ERK signaling pathway facilitates VSV-mediated oncolysis: Implication for the defective interferon response in cancer cells","volume":"15","author":"Noser","year":"2007","journal-title":"Mol Ther."},{"issue":"22","key":"key\n\t\t\t\t20181014195311135_djy033-B36","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.0901329106","article-title":"Impaired interferon signaling is a common immune defect in human cancer","volume":"106","author":"Critchley-Thorne","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"key\n\t\t\t\t20181014195311135_djy033-B37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jgm.1231","article-title":"Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma","volume":"10","author":"He","year":"2008","journal-title":"J Gene Med."},{"issue":"4","key":"key\n\t\t\t\t20181014195311135_djy033-B38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/hum.2009.111","article-title":"Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates","volume":"21","author":"Jenks","year":"2010","journal-title":"Hum Gene Ther."},{"issue":"8","key":"key\n\t\t\t\t20181014195311135_djy033-B39","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/JVI.65.8.4498-4501.1991","article-title":"Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein","volume":"65","author":"Staeheli","year":"1991","journal-title":"J Virol."},{"issue":"5","key":"key\n\t\t\t\t20181014195311135_djy033-B40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/156652305774329267","article-title":"Immune response to herpes simplex virus and y134.5 deleted HSV vectors","volume":"5","author":"Broberg","year":"2005","journal-title":"Current Gene Ther"},{"issue":"7","key":"key\n\t\t\t\t20181014195311135_djy033-B41","doi-asserted-by":"crossref","first-page":"e1000096","DOI":"10.1371\/journal.ppat.1000096","article-title":"Vaccinia virus E3 protein prevents the antiviral action of ISG15","volume":"4","author":"Guerra","year":"2008","journal-title":"PLoS Pathog."},{"issue":"10","key":"key\n\t\t\t\t20181014195311135_djy033-B42","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/MCB.01466-09","article-title":"Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification","volume":"30","author":"Shi","year":"2010","journal-title":"Mol Cell Biol."},{"issue":"32","key":"key\n\t\t\t\t20181014195311135_djy033-B43","doi-asserted-by":"crossref","first-page":"33165","DOI":"10.18632\/oncotarget.5320","article-title":"Vesicular stomatitis virus expressing interferon-beta is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer","volume":"6","author":"Patel","year":"2015","journal-title":"Oncotarget."},{"issue":"10","key":"key\n\t\t\t\t20181014195311135_djy033-B44","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cgt.2013.55","article-title":"Overcoming cancer cell resistance to VSV oncolysis with JAK1\/2 inhibitors","volume":"20","author":"Escobar-Zarate","year":"2013","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"key\n\t\t\t\t20181014195311135_djy033-B45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.virol.2012.11.014","article-title":"Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling","volume":"436","author":"Moerdyk-Schauwecker","year":"2013","journal-title":"Virology."},{"issue":"11","key":"key\n\t\t\t\t20181014195311135_djy033-B46","doi-asserted-by":"crossref","first-page":"e112014","DOI":"10.1371\/journal.pone.0112014","article-title":"Inhibitors of the interferon response enhance virus replication in vitro","volume":"9","author":"Stewart","year":"2014","journal-title":"PLoS One."},{"issue":"11","key":"key\n\t\t\t\t20181014195311135_djy033-B47","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/mt.2014.160","article-title":"CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy","volume":"22","author":"Engeland","year":"2014","journal-title":"Mol Ther."},{"issue":"226","key":"key\n\t\t\t\t20181014195311135_djy033-B48","doi-asserted-by":"crossref","first-page":"226ra32","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci Translat Med."},{"issue":"6","key":"key\n\t\t\t\t20181014195311135_djy033-B49","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/mt.2012.4","article-title":"Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus","volume":"20","author":"Iankov","year":"2012","journal-title":"Mol Ther."},{"issue":"4","key":"key\n\t\t\t\t20181014195311135_djy033-B50","first-page":"493","article-title":"Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment","volume":"19","author":"Hardcastle","year":"2017","journal-title":"Neuro-oncology."},{"issue":"341","key":"key\n\t\t\t\t20181014195311135_djy033-B51","doi-asserted-by":"crossref","first-page":"341ra75","DOI":"10.1126\/scitranslmed.aad9784","article-title":"Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma","volume":"8","author":"Cloughesy","year":"2016","journal-title":"Sci Translat Med."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/10\/1123\/26039140\/djy033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T01:41:09Z","timestamp":1603935669000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/10\/1123\/4994927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,5,16]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djy033","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,5,16]]}}}